Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 16, 2021Headache The Journal of Head and Face PainOpen Access

Understanding the migraine treatment landscape prior to the introduction of calcitonin gene‐related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study

View Full Paper
Ask AI
Bookmark
Share

Authors

AKAriane K. KawataIthaka HarborsNSNeel ShahUniversity of South FloridaJPJiat Ling PoonEli Lilly (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kawata et al. (2021) studied this question.

synapsesocial.com/papers/69dd4ae1fb7610310c101a0dhttps://doi.org/10.1111/head.14053
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability2001 · 1,224 citations
  2. 2A Real‐World Analysis of Migraine: A Cross‐Sectional Study of Disease Burden and Treatment Patterns2017 · 134 citations
  3. 3Migraine prevalence, disease burden, and the need for preventive therapy2007 · 2,373 citations
  4. 4The Effect of Psychiatric Comorbidities on Headache‐Related Disability in Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study2020 · 101 citations
  5. 5Assessing the Impact of Migraine2001 · 84 citations